Financials

Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.75
Price to sales ratio
1 507.32

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4537
BRNS
Barinthus Biotherapeutics plc - American Depositary Shares
0.61 USD0.00%-1.61%-12.86%-40.20%24.92 M USD
4548
MRKR
Marker Therapeutics, Inc. - Common Stock
1.44 USD-1.37%-13.77%+6.67%-8.28%24.01 M USD
4552
NXTC
NextCure, Inc. - Common Stock
6.58 USD+201.83%+239.18%+219.42%-49.77%23.77 M USD
4553
VYNE
VYNE Therapeutics Inc. - Common Stock
0.71 USD+7.58%+9.23%+16.39%-46.21%23.68 M USD

Frequently asked questions about NeuroSense Therapeutics Ltd. - Ordinary Shares

What is the NeuroSense Therapeutics Ltd. - Ordinary Shares stock price today?

The current price of NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) is 0.73. Over the past 24 hours, the stock has changed by 0.00%. Follow the NRSN chart for real-time price dynamics.

What is the stock ticker of NeuroSense Therapeutics Ltd. - Ordinary Shares?

NeuroSense Therapeutics Ltd. - Ordinary Shares trades under the ticker NRSN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is NeuroSense Therapeutics Ltd. - Ordinary Shares stock going up?

NRSN has changed by +7.35% over the last week, +5.80% over the last month, and -64.73% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does NeuroSense Therapeutics Ltd. - Ordinary Shares have?

As of the latest available data, NeuroSense Therapeutics Ltd. - Ordinary Shares has 16 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy NeuroSense Therapeutics Ltd. - Ordinary Shares stock?

You can buy NeuroSense Therapeutics Ltd. - Ordinary Shares (NRSN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in NeuroSense Therapeutics Ltd. - Ordinary Shares stock?

Investing in NeuroSense Therapeutics Ltd. - Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NRSN chart and related analysis on metatrader.com as part of your research.

News